23 Nov 2018 --- Three years after acquiring a majority shareholding of Gnosis, Lesaffre has today announced the full acquisition of the Italian biotechnology company. The acquisition seeks to combine the companies into a single unit to propose a unified range of products and services to its nutritional ingredients and human health customers and partners and to continue its growth in the fast-growing environment.
